Biomarkers for IgAN
HCPLive
NOVEMBER 18, 2024
Panelists discuss potential biomarkers and clinical indicators that can aid in predicting disease outcomes for individual patients with IgA nephropathy.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
HCPLive
NOVEMBER 18, 2024
Panelists discuss potential biomarkers and clinical indicators that can aid in predicting disease outcomes for individual patients with IgA nephropathy.
Med Page Today
AUGUST 2, 2024
(MedPage Today) -- PHILADELPHIA -- Blood biomarkers specific to Alzheimer's disease -- specifically, amyloid-beta 42/40 ratios and measures of phosphorylated tau 181 (p-tau181) -- had a relationship with subsequent dementia that started in.
Med Page Today
JULY 29, 2024
(MedPage Today) -- PHILADELPHIA -- Blood tests for Alzheimer's disease biomarkers may not only be useful for clinical diagnosis but could also make it possible to test preventive therapies in people not yet showing any signs of the condition.
Frontiers in Cardiovascular Medicine
JANUARY 23, 2024
As a result, numerous biomarkers have been investigated in an effort to identify and prevent certain diseases sooner. These biomarkers are typically linked to complications from HTX. We also highlight the relationships between each biomarker and one or more problems, as well as their applicability in routine clinical practice.
HCPLive
MAY 1, 2024
Urinary cytokines GDF-15, IL-6, and EGF significantly strengthened the predictability of IgAN prognosis and may be viable biomarker candidates for disease progression.
HCPLive
MAY 24, 2024
Igor Barjaktarevic, MD, PhD, provides insights on the evolving role of biomarkers in COPD, highlighting the role of eosinophils on informing treatment decisions.
Medical Xpress - Cardiology
JANUARY 11, 2024
Jude LIFE) have revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations in high-risk, asymptomatic childhood cancer survivors. Jude lifetime cohort study (St.
Med Page Today
MARCH 6, 2024
(MedPage Today) -- DENVER -- People with HIV who received semaglutide (Ozempic, Wegovy) had reduced levels of several inflammatory biomarkers associated with cardiovascular disease, a randomized controlled trial showed. After 32 weeks, interleukin.
HCPLive
JUNE 10, 2024
Strnad explains key findings from research presented at the EASL Congress regarding noninvasive testing and biomarkers in AATD-LD based on phase 2 fazirsiran clinical trials.
HCPLive
AUGUST 22, 2024
These data on systemic inflammatory biomarkers for patients with eczema may allow for more targeted treatments and for greater personalization of medicine for this skin condition.
DAIC
APRIL 22, 2024
This is an innovative platform for measuring biomarkers,” stated Dr. Karlsberg. This study highlights the value of digital biomarkers that may enable instantaneous feedback for care providers in assessing the patient. milla1cf Mon, 04/22/2024 - 15:05 April 22, 2024 — At the annual American College of Cardiology conference ( ACC.24
JAMA Cardiology
APRIL 5, 2024
This cohort study explores whether a novel artificial intelligence (AI) video-based biomarker for aortic stenosis is associated with development and progression of aortic stenosis.
American College of Cardiology
OCTOBER 9, 2024
What is the value of specific biomarkers for heart failure (HF) risk stratification in patients with atrial fibrillation (AF)?
Medical Xpress - Cardiology
JANUARY 25, 2024
An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes.
Nature Reviews - Cardiology
JULY 21, 2024
Nature Reviews Cardiology, Published online: 22 July 2024; doi:10.1038/s41569-024-01060-8 In this Roadmap arising from an NHLBI workshop, Chew and colleagues explore the use of retinal imaging biomarkers for the prediction, diagnosis and monitoring of systemic cardiovascular diseases.
Science Daily - Heart Disease
MARCH 18, 2024
Researchers have identified novel protein biomarkers that are associated with the development of CHD in people with and without diabetes. Coronary heart disease is a major global health problem, especially among people with type 2 diabetes.
HCPLive
SEPTEMBER 25, 2024
Findings from the prospective cohort study suggest the value of serum Z polymer levels as a non-invasive disease-specific biomarker in patients with homozygous ZZ AATD liver disease.
Circulation
NOVEMBER 11, 2024
In this study, we proposed and employed a novel approach combining traditional statistics and a nexus of cutting-edge AI/ML techniques to identify significant biomarkers for our predictive engine by analyzing the complete transcriptome of CVD patients (Figure 1).
Heart BMJ
SEPTEMBER 16, 2024
In this setting, circulating biomarkers, a component of the liquid biopsy, provide a promising approach for the fast, affordable and scalable screening of large numbers of patients, allowing the detection of different pathological features related to myocardial remodelling, aiding in risk stratification and therapy monitoring.
American College of Cardiology
OCTOBER 16, 2024
He then explores an analysis from COMBINE-AF on heart failure (HF) risk assessment using biomarkers in patients with atrial fibrillation. Eagle looks at an individual patient data meta-analysis of semaglutide and blood pressure (BP).
Journal of the American Heart Association
FEBRUARY 27, 2024
A group of 24 candidate biomarkers supported by prior literature was assessed at baseline and 24 weeks later. Longitudinal analyses examined the association between baseline biomarker values, measured in plasma EDTA, and the change in arterial inflammation target to background ratio. to 0.33 (likelihood ratioP=0.0005).ConclusionsA
Cardiovascular Diabetology
NOVEMBER 1, 2024
Dysglycemia and insulin resistance increase type 2 diabetes (T2D) and cardiovascular disease (CVD) risk, yet associations with specific glucose-insulin homeostatic biomarkers have been inconsistent. Vitamin D.
Medical Xpress - Cardiology
JANUARY 31, 2024
A collaborative cohort of researchers, led by University of Colorado Anschutz Medical Campus professor Angelo D'Alessandro, has identified kynurenine as a critical new biomarker in the quality of stored red blood cells (RBCs), a crucial step in the development of more personalized transfusions.
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Objective In patients with complex coronary artery disease (CAD) undergoing cardiac surgery, myocardial protection might be impaired due to microvascular obstruction, resulting in myocardial injury and subsequent biomarker release. Preoperatively, higher levels of cardiac biomarkers were found in patients with higher SYNTAX Score II.
Medical Xpress - Cardiology
MARCH 18, 2024
The research team investigated the predictive performance of protein biomarkers on incident CHD in individuals with and without T2D. Among middle-aged adults, individuals with type 2 diabetes (T2D) have a two to four times higher risk of developing CHD than people without T2D.
HCPLive
JUNE 5, 2024
The key opinion leaders explore the utilization of biomarkers in guiding the treatment of severe or uncontrolled asthma, discussing the specific role of eosinophils in informing therapeutic decision-making for patients with challenging asthma cases.
HCPLive
AUGUST 16, 2024
Strnad explains the need for noninvasive biomarkers in AATD liver disease and early research about circulating Z-polymer’s potential association with clinically relevant adverse outcomes.
Circulation
NOVEMBER 11, 2024
Exploring potential biomarkers from mitochondrial perspective may be effective in the diagnosis and treatment of PAH. Then, the potential biomarkers for PAH were accessed by single-cell data analysis, drug prediction, miRNA-transcription factor-mRNA network construction, and receiver operating characteristic curves.
Journal of Clinical Investigation - Cardiology
APRIL 1, 2024
There is unmet need for additional biomarkers to better select patients with non–small cell lung cancer (NSCLC) that are likely to benefit from immunotherapy in order to improve patient outcomes, reduce patient toxicity, and relieve the growing burden of healthcare costs.
Society of Thoracic Surgeons - Surgeon
NOVEMBER 16, 2023
Webinar Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC dkaczmarek Thu, 11/16/2023 - 16:01 December 14, 2023 Part 2 of a 2-part webinar series, supported by AstraZeneca This webinar will address preoperative biomarker testing and issues around neoadjuvant immunotherapy for NSCLC. Moderators Robert E.
Nature Reviews - Cardiology
MARCH 17, 2024
In this Review, Caporali and colleagues examine the biology of these molecules and discuss the potential of non-coding RNAs for translation to the clinic as biomarkers and therapeutics in adverse cardiac remodelling leading to ischaemic heart failure.
HCPLive
JANUARY 23, 2024
Wesley Mizutani, MD, discusses California's SB 496 legislation, which addresses the crucial role of biomarkers in guiding optimal drug selection to improve overall healthcare outcomes.
Stroke Journal
MARCH 24, 2024
While researchers in the Alzheimer disease field have been working for years to establish and test blood-based biomarkers for Alzheimer disease diagnosis, prognosis, clinical therapy discovery, and early detection, blood-based biomarkers for VCID are in their infancy and also face challenges.
Frontiers in Cardiovascular Medicine
JULY 17, 2024
This study employs bioinformatics approaches to identify common biomarkers and pathways between AS and ankylosing spondylitis.MethodsGene expression datasets for AS (GSE100927, GSE28829, GSE155512) and ankylosing spondylitis (GSE73754, GSE25101) were obtained from the Gene Expression Omnibus (GEO).
Heart BMJ
MAY 10, 2024
Biomarkers have dramatically impacted the way patients with HF are evaluated and managed. The most studied biomarkers in HF are natriuretic peptides (NPs). A timely diagnosis and initiation of evidence-based treatments are key to prevent hospitalisation and improve outcomes in this population.
Frontiers in Cardiovascular Medicine
MARCH 3, 2024
The goal of our study is to identify potential relationships between plasma biomarkers and cardiac magnetic resonance (CMR) imaging markers in patients with HFpEF. Partial least squares discriminant analysis (PLS-DA) was used to characterize CMR and biomarker variables that differentiate the subject groups into two principal components.
Society of Thoracic Surgeons - Surgeon
MAY 23, 2024
Video 8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC kchalko Thu, 05/23/2024 - 09:56 In this video in the 8 in 8 Series, Dr. Dwight Owen (Ohio State University) discussed advances in biomarker testing and neoadjuvant immunotherapy for resectable non-small cell lung cancer.
JAMA Cardiology
FEBRUARY 20, 2024
This substudy of a randomized clinical trial investigates the effects of pitavastatin on noncalcified coronary artery plaque using coronary computed tomography angiography and on inflammatory biomarkers as potential mechanisms for major adverse cardiovascular event prevention.
HCPLive
FEBRUARY 28, 2024
A study from Brigham and Women's Hospital has identified 6 blood-based biomarkers that may predict cardiovascular disease risk in rheumatoid arthritis patients.
Frontiers in Cardiovascular Medicine
AUGUST 11, 2024
The objectives of our study were to identify potential biomarkers for PV-related AS and to explore the molecular biological association between PV and AS.MethodsWe extracted microarray datasets from the Gene Expression Omnibus (GEO) dataset for PV and AS. The expression of potential biomarkers was validated using an external dataset.
HCPLive
FEBRUARY 19, 2024
In this Lungcast segment, Spicer spoke on several treatment-specific biomarkers for lung cancer and discussed the future of lung cancer therapy.
Science Daily - Heart Disease
JANUARY 11, 2024
Scientists have found that two common biomarkers could predict cardiomyopathy that is otherwise undetected by conventional screenings in childhood cancer survivors.
Medical Xpress - Cardiology
SEPTEMBER 2, 2024
Low concentrations of three selected biomarkers in the blood of patients with atrial fibrillation identify patients with a high chance of attaining sinus rhythm. This is the main result of this analysis of the EAST—AFNET 4 biomolecule study.
HCPLive
MAY 31, 2024
Using available literature, the review assesses our current understanding of AATD, emerging biomarkers, and the future of drug development.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content